Related Targets |
Target |
Mechanism KRAS G12C inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date12 Dec 2022 |
Target |
Mechanism KRAS G12C inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date28 May 2021 |
Target |
Mechanism KRAS G12C inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseNDA/BLA |
First Approval Ctry. / Loc.- |
First Approval Date- |
Start Date14 Oct 2024 |
Sponsor / Collaborator |
Start Date30 Apr 2024 |
Sponsor / Collaborator |
Start Date17 Apr 2024 |
Sponsor / Collaborator |